Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Oragenics Inc (NYSE MKT LLC:OGEN)

0.43
Delayed Data
As of Apr 28
 +0.03 / +7.50%
Today’s Change
0.31
Today|||52-Week Range
1.10
-20.37%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues1.0M939.9K1.2M0.00
 
 
 
 
Cost of Goods Sold343.4K341.9K410.6K0.00
 
 
 
 
Depreciation And Amortization76.5K27.7K71.2K75.0K
 
 
 
 
 
 
Operating ExpensesGross Income612.4K570.3K694.1K-75.0K
 
 
 
 
 
General Expenses16.8M6.4M12.3M8.5M
 
 
 
 
 
Other Operating Expenses0.000.000.004.8K
 
 
Research And Development9.3M3.1M8.8M4.8M
 
 
 
 
 
Total Operating Expenses17.2M6.8M12.8M8.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-16.2M-5.8M-11.7M-8.5M
 
 
 
 
 
Interest Expense On Debt17.5K4.0K76.7K4.1K
 
 
 
 
 
Other Expenses135.5K-6.0K-3.9K14.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-16.1M-5.8M-11.7M-8.5M
 
 
 
 
 
Discontinued Operations0.000.000.0030.3K
 
 
Extraordinary Items0.000.000.001.5M
 
 
Net Income-16.1M-5.8M-11.7M-8.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS28.8M36.2M36.7M44.6M
 
 
 
 
 
Shares To Calculate EPS Diluted28.8M36.2M36.7M44.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.56-$0.16-$0.32-$0.16
 
 
 
 
 
EPS Diluted-$0.56-$0.16-$0.32-$0.19